Back
OptimizeRx Stock Price Chart
Sell
49
OPRX
OptimizeRx
Last Price:
12.05
Seasonality Move:
5.75%
7 Day Trial
ALL ACCESS PASS
$
7
- The current trend is moderately bullish and OPRX is experiencing slight selling pressure.
OptimizeRx Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.47 | Sell |
20-day SMA: | 11.84 | Buy |
50-day SMA: | 11.12 | Buy |
200-day SMA: | 11.16 | Buy |
8-day EMA: | 12.29 | Sell |
20-day EMA: | 11.92 | Buy |
50-day EMA: | 11.79 | Buy |
200-day EMA: | 12.49 | Sell |
OptimizeRx Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.4 | Buy |
Relative Strength Index (14 RSI): | 53.26 | Buy |
Chaikin Money Flow: | -68032 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.43 - 12.63) | Buy |
Bollinger Bands (100): | (10.84 - 15.2) | Sell |
OptimizeRx Technical Analysis
May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for OptimizeRx Stock
Is OptimizeRx Stock a Buy?
- OptimizeRx share price is 12.06 while OPRX 8-day simple moving average is 12.47, which is a Sell signal.
- The stock price of OPRX is 12.06 while OptimizeRx 20-day SMA is 11.84, which makes it a Buy.
- OptimizeRx 50-day simple moving average is 11.12 while OPRX share price is 12.06, making it a Buy technically.
- OPRX stock price is 12.06 and OptimizeRx 200-day simple moving average is 11.16, creating a Buy signal.
OPRX Technical Analysis vs Fundamental Analysis
Sell
49
OptimizeRx (OPRX)
is a Sell
Is OptimizeRx a Buy or a Sell?
-
OptimizeRx stock is rated a Sell
The current OptimizeRx [OPRX] share price is $12.06. The Score for OPRX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
OptimizeRx Stock Info
Market Cap:
220.33M
Price in USD:
12.06
Share Volume:
170.08K
OptimizeRx 52-Week Range
52-Week High:
16.65
52-Week Low:
6.92
Sell
49
OptimizeRx (OPRX)
is a Sell
OptimizeRx Share Price Forecast
-
What is the OptimizeRx stock price today?
The OptimizeRx stock price is 12.06 USD today. -
Will OPRX stock go up or go down?
OptimizeRx> share price is forecast to RISE/FALL based on technical indicators -
Is OptimizeRx overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, OptimizeRx is overvalued.
Is OptimizeRx Stock a Buy?
- OptimizeRx share price is 12.06 while OPRX 8-day exponential moving average is 12.29, which is a Sell signal.
- The stock price of OPRX is 12.06 while OptimizeRx 20-day EMA is 11.92, which makes it a Buy.
- OptimizeRx 50-day exponential moving average is 11.79 while OPRX share price is 12.06, making it a Buy technically.
- OPRX stock price is 12.06 and OptimizeRx 200-day simple moving average is 12.49, creating a Sell signal.
Fundamental Analysis of OptimizeRx
Is OptimizeRx a good investment?
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.07 per share, and an increase next year of $0.19 per share.
Technical Analysis of OptimizeRx
Should I short OptimizeRx stock?
- OPRX Moving Average Covergence Divergence (MACD) indicator is 0.4, suggesting OptimizeRx is a Buy
- OptimizeRx Relative Strength Index (RSI) is 53.26, which suggest OptimizeRx is overbought
- The Bollinger Bands (25) for OptimizeRx is (10.43 - 12.63), which suggest OptimizeRx is a Sell
- The Bollinger Bands (100) for OptimizeRx is (10.84 - 15.2), which suggest OptimizeRx is a Sell
* OptimizeRx stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.